4//SEC Filing
Caissa Capital Management ltd. 4
Accession 0001929354-23-000013
CIK 0001534120other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:24 PM ET
Size
9.8 KB
Accession
0001929354-23-000013
Insider Transaction Report
Form 4
Caissa Capital Management ltd.
10% Owner
Transactions
- Purchase
Common Stock
2023-06-08$3.93/sh+6,398$25,126→ 1,395,597 total(indirect: See Footnote (1)) - Purchase
Common Stock
2023-06-07$3.49/sh+2,984$10,418→ 1,389,199 total(indirect: See Footnote (1)) - Purchase
Common Stock
2023-06-09$4.14/sh+5,044$20,896→ 1,400,641 total(indirect: See Footnote (1))
Holdings
- 182,300
Common Stock
Footnotes (5)
- [F1]Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.90 to $3.6, inclusive.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.775 to $4.22, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.01 to $4.3, inclusive.
- [F5]These shares are directly owned by Mr. Golestaneh in his personal capacity.
Documents
Issuer
Avalo Therapeutics, Inc.
CIK 0001534120
Entity typeother
IncorporatedVirgin Islands, British
Related Parties
1- filerCIK 0001929354
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 4:24 PM ET
- Size
- 9.8 KB